Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Pfizer (NY: PFE)
44.37 USD  -0.13 (-0.29%)
Official Closing Price  /  Updated: 5:50 PM EDT, Oct 22, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 16,851,534
Open 44.44
Bid (Size) 44.21 (5)
Ask (Size) 44.50 (30)
Prev. Close 44.50
Today's Range 44.02 - 44.51
52wk Range 33.20 - 45.81
Shares Outstanding 5,849,571,048
Dividend Yield 3.02%
Performance
YTD
+21.76%
+21.76%
1 Month
+0.70%
+0.70%
3 Month
+19.24%
+19.24%
6 Month
+20.57%
+20.57%
1 Year
+21.90%
+21.90%
Top News
More News
Pfizer Presents Overall Survival Data From PALOMA-3 Trial of IBRANCE® (palbociclib) in Patients With HR+, HER2- Metastatic Breast Cancer
Pfizer Inc.(NYSE:PFE) today announced detailed overall survival (OS) data from the PALOMA-3 trial, which evaluated IBRANCE® (palbociclib) in combination with fulvestrant compared to placebo plus... Read More
from Business Wire News Releases
Pfizer Offers Early Retirement Ahead of Layoffs Next Year
category best pharmaceutical stocks , drug manufacturers industry , drugs manufacturer , and 19 more.
from Street Signals
More News
Read More
Notable ETF Inflow Detected - SPLG, PFE, UNH, C
category ETFs
from ETF Channel
AstraZeneca's Lynparza shown to put brakes on ovarian cancer
category companyNews
from Reuters: Company News
2018 Dogs Of The Dow
category Stocks / Equities
from Blogs - TalkMarkets
UPDATE 1-Australian watchdog's appeal against Pfizer ruling dismissed by court
category companyNews
from Reuters: Company News
Court dismisses Australian watchdog's appeal against Pfizer ruling
category companyNews
from Reuters: Company News
Investor 'Hand-Wringing' Continues As Tiny Biotech Takes On Pfizer
from Investor's Business Daily
Dow stocks Pfizer and UnitedHealth could be safety plays amid market volatility
category Merck & Co Inc , Investing , Investment strategy , and 6 more.
from CNBC.com News
Bearish Moving Average Cross by Pfizer Inc (PFE)
from Comtex SmarTrend® News Briefs
Merck, Pfizer combo treatment meets main goals of kidney cancer trial
category companyNews
from Reuters: Company News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
X